Indoco’s Q1 margin rebound hinges on USFDA audit timing
Indoco Remedies Limited — Q1 FY27 Earnings Call (Quarter ended 30 June 2026) 1. Overall Tone of Management Optimistic. Management repeatedly emphasizes “maintained its growth trajectory,” “operating momentum,” and “confident…to sustain profitable growth.” They also frame…
